
What Predicts Better Recovery After DCM Surgery? The Importance of Timing and Pain Control
Surgery is the standard treatment for Degenerative Cervical Myelopathy (DCM) and often helps by stopping the spinal cord from deteriorating further. However, many people notice that recovery is not the same for everyone. Some patients regain useful function, while others continue to struggle with issues such as walking difficulty, hand clumsiness, or bladder symptoms — even after technically “successful” surgery.
A recent multicentre study by Nagoshi and colleagues explored why outcomes vary by looking at which clinical factors are linked with better function and quality of life after surgery, using a patient-focused questionnaire called the JOACMEQ [1].
How Was This Study Conducted?
The researchers prospectively followed 935 people undergoing surgery for DCM across 10 institutions in Japan, with 852 patients included in the final analysis (those with complete questionnaire data). Patients were followed for 2 years after surgery.
Instead of relying only on clinician-scored measures, they used the JOACMEQ (Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire) — a questionnaire designed specifically for people with cervical myelopathy. It captures daily-life function across five areas:
- Cervical (neck) function (e.g., turning the head, drinking)
- Upper limb function (e.g., buttons, eating)
- Lower limb function (e.g., walking, stairs)
- Bladder function (e.g., urgency, incontinence)
- Quality of life (QOL) (how health affects daily life and wellbeing)
They also measured pain using a VAS (visual analogue scale) — a common 0–100 scale where higher numbers mean worse pain — and recorded factors such as age, BMI (body mass index), symptom duration, comorbidities (other health conditions), and complications.
What Were The Findings?
Overall, surgery led to improved neurological scores and reduced pain for many patients. However, when outcomes were broken down by JOACMEQ domains, improvement varied a lot depending on the function being assessed.
At 2 years, the proportion of patients who achieved an “effective” improvement was:
- 49.6% for neck function
- 48.5% for upper limb function
- 35.1% for lower limb function
- 23.2% for bladder function
- 23.8% for overall quality of life
In simple terms: about half of patients showed meaningful improvement in neck and arm function, but improvements were less common for walking, bladder symptoms, and overall quality of life.
Why Does This Matter?
This study helps explain why two people can have the same diagnosis and surgery, but experience very different recoveries. The key message is that outcomes weren’t only linked to the operation itself — they were strongly associated with:
- How long symptoms had been present before surgery, and
- How much pain remained at long-term follow-up
The authors found that longer symptom duration was consistently linked with worse outcomes in several areas — including arm function, leg function, bladder function, and quality of life. This supports what many clinicians and patients suspect: the longer the spinal cord is compressed, the harder it may be to fully recover certain functions.
They also found that residual pain mattered. Persistent neck and arm pain at 2 years was linked with poorer quality of life, even if neurological scores improved. This is important because pain can shape daily life, mood, sleep, and confidence with movement — and may be a major driver of whether someone feels they are truly “better”.
What Do These Findings Mean?
The findings point to a few practical takeaways for DCM care:
- Timing matters. Shorter symptom duration was linked with better outcomes across multiple domains. This strengthens the case for early recognition of DCM symptoms and timely specialist assessment.
- Pain deserves serious attention. People can have technically successful decompression and still have a reduced quality of life if pain persists. Better post-operative pain strategies and rehabilitation may be crucial for maximising recovery.
- Recovery is multi-dimensional. Traditional clinician-scored measures (like the JOA or mJOA) are useful, but they can miss what matters most to patients in everyday life — including bladder function and quality of life. Tools like the JOACMEQ help make those outcomes visible.
We commend the authors for using a large, prospective dataset and focusing on patient-reported outcomes, which better reflect real-world recovery. Studies like this support more personalised counselling — not only about the chances of neurological improvement, but also about the likely recovery of walking, bladder symptoms, and quality of life.
If you found this summary helpful, consider sharing it to raise awareness of DCM, support the Myelopathy.org community, and encourage earlier recognition and better recovery support for people living with myelopathy.
Want to Learn More?
[1] Nagoshi N, Yamane J, Okubo T, et al. Clinical Indicators of Surgical Outcomes in Degenerative Cervical Myelopathy Assessed Using the JOACMEQ: A Prospective Multicenter Study. Spine. 2025;50(19):1319–1326. doi: 10.1097/BRS.0000000000005428
